Cargando…
Modeling Superimposed Preeclampsia Using Ang II (Angiotensin II) Infusion in Pregnant Stroke-Prone Spontaneously Hypertensive Rats
Hypertensive disorders of pregnancy are the second leading cause of maternal deaths worldwide. Superimposed preeclampsia is an increasingly common problem and often associated with impaired placental perfusion. Understanding the underlying mechanisms and developing treatment options are crucial. The...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott, Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6012051/ https://www.ncbi.nlm.nih.gov/pubmed/29844145 http://dx.doi.org/10.1161/HYPERTENSIONAHA.118.10935 |
_version_ | 1783333888936902656 |
---|---|
author | Morgan, Hannah L. Butler, Elaine Ritchie, Shona Herse, Florian Dechend, Ralf Beattie, Elisabeth McBride, Martin W. Graham, Delyth |
author_facet | Morgan, Hannah L. Butler, Elaine Ritchie, Shona Herse, Florian Dechend, Ralf Beattie, Elisabeth McBride, Martin W. Graham, Delyth |
author_sort | Morgan, Hannah L. |
collection | PubMed |
description | Hypertensive disorders of pregnancy are the second leading cause of maternal deaths worldwide. Superimposed preeclampsia is an increasingly common problem and often associated with impaired placental perfusion. Understanding the underlying mechanisms and developing treatment options are crucial. The pregnant stroke-prone spontaneously hypertensive rat has impaired uteroplacental blood flow and abnormal uterine artery remodeling. We used Ang II (angiotensin II) infusion in pregnant stroke-prone spontaneously hypertensive rats to mimic the increased cardiovascular stress associated with superimposed preeclampsia and examine the impact on the maternal cardiovascular system and fetal development. Continuous infusion of Ang II at 500 or 1000 ng/kg per minute was administered from gestational day 10.5 until term. Radiotelemetry and echocardiography were used to monitor hemodynamic and cardiovascular changes, and urine was collected prepregnancy and throughout gestation. Uterine artery myography assessed uteroplacental vascular function and structure. Fetal measurements were made at gestational day 18.5, and placentas were collected for histological and gene expression analyses. The 1000 ng/kg per minute Ang II treatment significantly increased blood pressure (P<0.01), reduced cardiac output (P<0.05), and reduced diameter and increased stiffness of the uterine arteries (P<0.01) during pregnancy. The albumin:creatinine ratio was increased in both Ang II treatment groups (P<0.05; P<0.0001). The 1000 ng/kg per minute–treated fetuses were significantly smaller than vehicle treatment (P<0.001). Placental expression of Ang II receptors was increased in the junctional zone in 1000 ng/kg per minute Ang II–treated groups (P<0.05), with this zone showing depletion of glycogen content and structural abnormalities. Ang II infusion in pregnant stroke-prone spontaneously hypertensive rats mirrors hemodynamic, cardiac, and urinary profiles observed in preeclamptic women, with evidence of impaired fetal growth. |
format | Online Article Text |
id | pubmed-6012051 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Lippincott, Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-60120512018-07-02 Modeling Superimposed Preeclampsia Using Ang II (Angiotensin II) Infusion in Pregnant Stroke-Prone Spontaneously Hypertensive Rats Morgan, Hannah L. Butler, Elaine Ritchie, Shona Herse, Florian Dechend, Ralf Beattie, Elisabeth McBride, Martin W. Graham, Delyth Hypertension Original Articles Hypertensive disorders of pregnancy are the second leading cause of maternal deaths worldwide. Superimposed preeclampsia is an increasingly common problem and often associated with impaired placental perfusion. Understanding the underlying mechanisms and developing treatment options are crucial. The pregnant stroke-prone spontaneously hypertensive rat has impaired uteroplacental blood flow and abnormal uterine artery remodeling. We used Ang II (angiotensin II) infusion in pregnant stroke-prone spontaneously hypertensive rats to mimic the increased cardiovascular stress associated with superimposed preeclampsia and examine the impact on the maternal cardiovascular system and fetal development. Continuous infusion of Ang II at 500 or 1000 ng/kg per minute was administered from gestational day 10.5 until term. Radiotelemetry and echocardiography were used to monitor hemodynamic and cardiovascular changes, and urine was collected prepregnancy and throughout gestation. Uterine artery myography assessed uteroplacental vascular function and structure. Fetal measurements were made at gestational day 18.5, and placentas were collected for histological and gene expression analyses. The 1000 ng/kg per minute Ang II treatment significantly increased blood pressure (P<0.01), reduced cardiac output (P<0.05), and reduced diameter and increased stiffness of the uterine arteries (P<0.01) during pregnancy. The albumin:creatinine ratio was increased in both Ang II treatment groups (P<0.05; P<0.0001). The 1000 ng/kg per minute–treated fetuses were significantly smaller than vehicle treatment (P<0.001). Placental expression of Ang II receptors was increased in the junctional zone in 1000 ng/kg per minute Ang II–treated groups (P<0.05), with this zone showing depletion of glycogen content and structural abnormalities. Ang II infusion in pregnant stroke-prone spontaneously hypertensive rats mirrors hemodynamic, cardiac, and urinary profiles observed in preeclamptic women, with evidence of impaired fetal growth. Lippincott, Williams & Wilkins 2018-07 2018-05-29 /pmc/articles/PMC6012051/ /pubmed/29844145 http://dx.doi.org/10.1161/HYPERTENSIONAHA.118.10935 Text en © 2018 The Authors. Hypertension is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited. |
spellingShingle | Original Articles Morgan, Hannah L. Butler, Elaine Ritchie, Shona Herse, Florian Dechend, Ralf Beattie, Elisabeth McBride, Martin W. Graham, Delyth Modeling Superimposed Preeclampsia Using Ang II (Angiotensin II) Infusion in Pregnant Stroke-Prone Spontaneously Hypertensive Rats |
title | Modeling Superimposed Preeclampsia Using Ang II (Angiotensin II) Infusion in Pregnant Stroke-Prone Spontaneously Hypertensive Rats |
title_full | Modeling Superimposed Preeclampsia Using Ang II (Angiotensin II) Infusion in Pregnant Stroke-Prone Spontaneously Hypertensive Rats |
title_fullStr | Modeling Superimposed Preeclampsia Using Ang II (Angiotensin II) Infusion in Pregnant Stroke-Prone Spontaneously Hypertensive Rats |
title_full_unstemmed | Modeling Superimposed Preeclampsia Using Ang II (Angiotensin II) Infusion in Pregnant Stroke-Prone Spontaneously Hypertensive Rats |
title_short | Modeling Superimposed Preeclampsia Using Ang II (Angiotensin II) Infusion in Pregnant Stroke-Prone Spontaneously Hypertensive Rats |
title_sort | modeling superimposed preeclampsia using ang ii (angiotensin ii) infusion in pregnant stroke-prone spontaneously hypertensive rats |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6012051/ https://www.ncbi.nlm.nih.gov/pubmed/29844145 http://dx.doi.org/10.1161/HYPERTENSIONAHA.118.10935 |
work_keys_str_mv | AT morganhannahl modelingsuperimposedpreeclampsiausingangiiangiotensiniiinfusioninpregnantstrokepronespontaneouslyhypertensiverats AT butlerelaine modelingsuperimposedpreeclampsiausingangiiangiotensiniiinfusioninpregnantstrokepronespontaneouslyhypertensiverats AT ritchieshona modelingsuperimposedpreeclampsiausingangiiangiotensiniiinfusioninpregnantstrokepronespontaneouslyhypertensiverats AT herseflorian modelingsuperimposedpreeclampsiausingangiiangiotensiniiinfusioninpregnantstrokepronespontaneouslyhypertensiverats AT dechendralf modelingsuperimposedpreeclampsiausingangiiangiotensiniiinfusioninpregnantstrokepronespontaneouslyhypertensiverats AT beattieelisabeth modelingsuperimposedpreeclampsiausingangiiangiotensiniiinfusioninpregnantstrokepronespontaneouslyhypertensiverats AT mcbridemartinw modelingsuperimposedpreeclampsiausingangiiangiotensiniiinfusioninpregnantstrokepronespontaneouslyhypertensiverats AT grahamdelyth modelingsuperimposedpreeclampsiausingangiiangiotensiniiinfusioninpregnantstrokepronespontaneouslyhypertensiverats |